Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

HCA Healthcare Q3 2026 Results: Net Income $1.58B, Down 3.9% YoY

HCA Healthcare reported revenues of $19.849 billion for the third quarter of 2026, a 3.6% increase over the prior year, while net income attributable to the company slightly decreased to $1.579 billion. Despite the slight dip in net income, diluted earnings per share rose to $7.27 from $6.96, driven by significant share repurchases totaling $6.605 billion during the first nine months of the year.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue19,849.019,161.0
Profit before tax2,370.02,418.0
Net income1,579.01,643.0
EPS (diluted, $ a share)$7.27$6.96

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-3.9%
Revenue, year on year+3.6%
Source

10-Q filed with the SEC, NYSE: HCA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

HCA Healthcare, Inc.: key numbers

Share price
$511.78Close, Nov 16
Market cap
$107B
Shares outstanding
208.89MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-General Medical & Surgical Hospitals, NECSIC 8062

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from HCA Healthcare, Inc.

All →
5:09 PM ET Form 4
Insider Selling

HCA Healthcare SVP & Chief Nurse Executive Erica Rossitto Sells $1.77M of Stock

Erica Rossitto, SVP & Chief Nurse Executive, sold 3,500 shares of HCA Healthcare, Inc. at $505.81 a share, worth $1.77M in total on Nov 10, 2026. Shares held after the trade: 13,426 (-20.7%).

Value
$1.77M
Shares
3,500
Price
$505.81
Role
SVP & Chief Nurse Executive
Holding change
-20.7%
Trade date
Nov 10, 2026
5:12 PM ET Form 4
Insider Selling

HCA Healthcare EVP and Chief Clinical Officer Michael J. Schlosser Sells $594K of Stock

Michael J. Schlosser, EVP and Chief Clinical Officer, sold 1,200 shares of HCA Healthcare, Inc. at $494.65 a share, worth $594K in total on Nov 4, 2026. Shares held after the trade: 1,443 (-45.4%).

Value
$594K
Shares
1,200
Price
$494.65
Role
EVP and Chief Clinical Officer
Holding change
-45.4%
Trade date
Nov 4, 2026
5:10 PM ET Form 4
Insider Selling

HCA Healthcare EVP and COO Jon M. Foster Sells $15.9M of Stock

Jon M. Foster, EVP and COO, sold 31,713 shares of HCA Healthcare, Inc. at $491.98 to $514.07 a share (average $500.98) in 8 transactions, worth $15.9M in total between Nov 4, 2026 and Nov 6, 2026. Shares held after the trade: 10,000 (-12.9%).

Value
$15.9M
Shares
31,713
Average price
$500.98
Role
EVP and COO
Holding change
-12.9%
Trade date
Nov 4, 2026 to Nov 6, 2026
4:22 PM ET 8-K
Loan & Debt

HCA Healthcare $6.5B Debt Financing with CSC Delaware Trust Company

HCA Healthcare's subsidiary, HCA Inc., completed a massive $6.5 billion public offering of senior notes across seven different tranches with maturities ranging from 2028 to 2056. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, Inc. and were issued under a shelf registration statement to manage the company's long-term capital structure.

Value
$6.5B
Counterparty
CSC Delaware Trust Company
Term
through 2056
5:04 PM ET 8-K
Loan & Debt

HCA Healthcare $1.2B Debt Financing with Mizuho Securities USA LLC

HCA Healthcare's subsidiary, HCA Inc., has commenced a public offering of senior unsecured notes to fund general corporate purposes. The company intends to use the proceeds to redeem $1.200 billion of its 4.500% senior notes due February 2027 and repay borrowings under its commercial paper program and credit facility.

Value
$1.2B
Counterparty
Mizuho Securities USA LLC
Term
through Feb 2027
7:18 AM ET 8-K
Financial Results

HCA Healthcare Financial Results

HCA Healthcare reported third quarter 2026 revenues of $19.85 billion, a 3.6% increase year-over-year, despite an estimated $400 million headwind from an unfavorable payer mix shift. The company also declared a quarterly cash dividend of $0.78 per share and indicated that full-year results are expected to be in the upper half of its previously issued guidance range.

Term
Q3 2026

“I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities, and our disciplined culture. Despite the challenges brought about by federal policy changes this year, our colleagues have continued to provide high-quality care to patients, and we believe HCA Healthcare is positioned to end the year positively.”

Sam Hazen, Chief Executive Officer of HCA Healthcare

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.